Carine Claeys

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Raffael Nachbagauer, Jodi Feser, Abdollah Naficy et al. · Nature Medicine · 2020 · 342 citations · Full text

Vaccination, Cross-protection, Vaccine Development +10

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

Janet E. McElhaney, Jeanne‐Marie Devaster, Meral Esen et al. · The Lancet Infectious Diseases · 2013 · 161 citations

Vaccination, Vaccine Safety, Cross-protection +10

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

David I. Bernstein, Jeffrey T. Guptill, Abdollah Naficy et al. · The Lancet Infectious Diseases · 2019 · 138 citations · Full text

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years

Dorothee Kieninger, Eric Sheldon, Wen‐Yuan Lin et al. · BMC Infectious Diseases · 2013 · 103 citations · Full text

A Randomized Trial of Candidate Inactivated Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccines in Children Aged 3–17 Years

Joseph B. Domachowske, Heidemarie Pankow-Culot, Milagros Bautista et al. · The Journal of Infectious Diseases · 2013 · 103 citations · Full text